hwk-007
·Code: HWK-007
hwk-007: developed by 1 company · 1 clinical trial tracked. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| Whitehawk Therapeutics, Inc. (WHWK) | Phase 1 |
Clinical Trials (1)
A Phase 1 First-in-Human Study of PTK7-Directed Antibody Drug Conjugate HWK-007 in Participants With Advanced Solid Tumors
Frequently asked questions
Who is developing hwk-007?
hwk-007 is being developed by Whitehawk Therapeutics, Inc..
How many clinical trials involve hwk-007?
BioSniper tracks 1 clinical trial involving hwk-007.
Get deeper analysis on hwk-007
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis